Parathyroid glands are crucial in the regulation of serum calcium levels. Parathyroid disorders have severely affected human health, causing long-term effects on multiple systems of the human body. There is an increasing appreciation for investigating advanced therapeutic strategies for parathyroid disorders, including parathyroid gland transplantation, molecularly targeted drugs for the treatment of parathyroid cancer, and calcimimetics for the treatment of hyperparathyroidism.
This Research Topic aims at talking about advances in the treatment of parathyroid disorders, including hypo- or hyper-parathyroidism, parathyroid glands transplantation, tumors of parathyroid glands, and complications in the treatment of parathyroid disorders.
Potential topics include but are not limited to:
• Internal and external regulators of PTH (Parathyroid hormone) / serum Ca2+;
• Impact factors of primary, secondary and pseudo hypoparathyroidism;
• Impact factors of primary, secondary and tertiary hyperparathyroidism;
• Advances in parathyroid glands autotransplantation, allotransplantation and xenotransplantation;
• Tumors of the parathyroid glands and the association of PTH / serum Ca2+;
• Possible therapeutic options for hypoparathyroidism based on PTH analogues and small molecule compounds;
• Hyperurinary calcium, hyperphosphatemia and kidney stones in the treatment of parathyroid disorders;
• Therapeutic options for improving the outcome of hypoparathyroidism or hypocalcemia.
Parathyroid glands are crucial in the regulation of serum calcium levels. Parathyroid disorders have severely affected human health, causing long-term effects on multiple systems of the human body. There is an increasing appreciation for investigating advanced therapeutic strategies for parathyroid disorders, including parathyroid gland transplantation, molecularly targeted drugs for the treatment of parathyroid cancer, and calcimimetics for the treatment of hyperparathyroidism.
This Research Topic aims at talking about advances in the treatment of parathyroid disorders, including hypo- or hyper-parathyroidism, parathyroid glands transplantation, tumors of parathyroid glands, and complications in the treatment of parathyroid disorders.
Potential topics include but are not limited to:
• Internal and external regulators of PTH (Parathyroid hormone) / serum Ca2+;
• Impact factors of primary, secondary and pseudo hypoparathyroidism;
• Impact factors of primary, secondary and tertiary hyperparathyroidism;
• Advances in parathyroid glands autotransplantation, allotransplantation and xenotransplantation;
• Tumors of the parathyroid glands and the association of PTH / serum Ca2+;
• Possible therapeutic options for hypoparathyroidism based on PTH analogues and small molecule compounds;
• Hyperurinary calcium, hyperphosphatemia and kidney stones in the treatment of parathyroid disorders;
• Therapeutic options for improving the outcome of hypoparathyroidism or hypocalcemia.
